Most Popular Stories
- Competitor hospitals form joint cardiology physician practice
- Humana slammed after posting 65 percent increase in third quarter profits
- CCHIT halts ARRA certification until it can be accredited
- Push for meaningful use leads to consolidation of two HIEs
- CIOs optimistic despite slow growth in HIT spending
- HIMSS10: Infrastructure planning breeds success in mobile healthcare
Featured Jobs
-
Internal Medicine Job in Michigan
StaffPointe, LLC - north central, MI -
Internal Medicine Job in South Carolina
StaffPointe, LLC - near Augusta, GA, SC -
Internal Medicine Job in Oregon
StaffPointe, LLC - Portland, OR -
RN Jobs in California
StaffPointe, LLC - Fresno, CA -
Nephrologist Job in Washington
StaffPointe, LLC - near Spokane, WA
Events
- The Burrill Consumer Digital Health Meeting
March 22-23, 2010 — SFO Marriott, Burlingame, CA - Hot Topics In Patient Care Device Integration Free Webinar
March 31st - mScholar Virtual Study PMP Exam Prep for Project Managers
April 22 - Healthcare IT Institute
May 2nd-4th — Atlanta, GA
Paid Research Reports
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
- Pipeline and Commercial Insight: Supportive Care in Oncology
- Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
- The Gastrointestinal Market Outlook To 2014: Market dynamics, competitive landscape, emerging therapies
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
FDA approves limited shipments of Fluvirin
The Food and Drug Administration approved three lots of Chiron's flu vaccine Fluvirin for general distribution, easing fears of a possible vaccine shortage for the 2005 flu season. The approval means up to 1.5 million doses of Fluvirin will be shipped within the next few days. The Wall Street Journal ran a major story on a potential flu vaccine shortage Monday, which raised the possibility that supply problems could follow if Chiron was not able to deliver. Skeptics note that the company still lags far behind its competition and wonder if it will be able to come near its projected shipment of 15 million to 28 million doses.
- see this article from the San Jose Mercury News
Related Stories
- FDA upbeat on prospects for Chiron flu vaccine
- FDA releases new guidelines
- Sanofi's H5N1 vaccine shows promise
- Chiron warns on vaccine production again
- Signs point to flu vaccine shortage
- CDC releases flu vaccination plan
- Chiron reports contamination problem at European facility
- FDA looking to reduce radiation exposure to patients
- Liquid Tamiflu shortage puts pressure on pharmacists, parents
- New IV flu drug approved for H1N1 use; First ED goes live on Calif. health info network;
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2010 FierceMarkets. All rights reserved. |
![]() |





